Skeletal manifestations of renal disease in childhood
- PMID: 27219042
- DOI: 10.1097/MNH.0000000000000233
Skeletal manifestations of renal disease in childhood
Abstract
Purpose of review: This review summarizes recent findings on musculoskeletal health in three chronic renal conditions of childhood: chronic kidney disease stages 2-5D, nephrotic syndrome, and urolithiasis. Findings with important clinical implications warranting further investigation are highlighted.
Recent findings: Recent cohort studies have demonstrated a high burden of fracture and progressive deficits of cortical bone in children with chronic kidney disease. Lower cortical density is associated with incident fracture and may be an important therapeutic target. Parathyroid hormone and calcium are independent correlates of cortical density, and modifiable factors for fracture include parathyroid hormone and phosphate binder use. Children with nephrotic syndrome, even with normal renal function, have evidence of abnormal bone metabolism and structure, and vitamin D deficiency may be an important modifiable risk factor in this population. Urolithiasis has been associated with reduced bone mineral density and is increasingly common in children and adolescents. Population-based data found a significantly increased risk of fracture in adolescent males and young women.
Summary: Recent findings substantiate concern regarding the particular vulnerability of the growing skeleton to chronic renal disease. Studies are needed to determine how to optimize assessment and management of bone health in children with these conditions, particularly in terms of calcium and vitamin D requirements, with the goal of improving childhood bone accrual for lifelong fracture prevention.
Similar articles
-
Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.Kidney Int. 2017 Dec;92(6):1343-1355. doi: 10.1016/j.kint.2017.07.021. Epub 2017 Sep 28. Kidney Int. 2017. PMID: 28964571 Review.
-
Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease.J Clin Endocrinol Metab. 2013 May;98(5):1930-8. doi: 10.1210/jc.2012-4188. Epub 2013 Apr 1. J Clin Endocrinol Metab. 2013. PMID: 23547048 Free PMC article.
-
Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.Nephrol Dial Transplant. 2008 Nov;23(11):3670-6. doi: 10.1093/ndt/gfn339. Epub 2008 Jun 24. Nephrol Dial Transplant. 2008. PMID: 18579534 Clinical Trial.
-
[Vitamin D metabolism of the bone].Orthopade. 2015 Sep;44(9):686-694. doi: 10.1007/s00132-015-3135-7. Orthopade. 2015. PMID: 26201944 German.
-
[Bone and Calcium Research Update 2015. Regulation of calcium in CKD].Clin Calcium. 2015 Jan;25(1):79-85. Clin Calcium. 2015. PMID: 25530525 Review. Japanese.
Cited by
-
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome.Pediatr Nephrol. 2020 Aug;35(8):1529-1561. doi: 10.1007/s00467-020-04519-1. Epub 2020 May 7. Pediatr Nephrol. 2020. PMID: 32382828 Free PMC article. Review.
-
Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2-5 and on dialysis.Nephrol Dial Transplant. 2017 Jul 1;32(7):1114-1127. doi: 10.1093/ndt/gfx080. Nephrol Dial Transplant. 2017. PMID: 28873971 Free PMC article.
-
Bone Disorders in Pediatric Chronic Kidney Disease: A Literature Review.Biology (Basel). 2023 Nov 2;12(11):1395. doi: 10.3390/biology12111395. Biology (Basel). 2023. PMID: 37997994 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials